164 related articles for article (PubMed ID: 34922454)
1. Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study.
Beca JM; Chan KKW; Naimark DMJ; Pechlivanoglou P
BMC Med Res Methodol; 2021 Dec; 21(1):282. PubMed ID: 34922454
[TBL] [Abstract][Full Text] [Related]
2. Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study.
Gallacher D; Kimani P; Stallard N
Med Decis Making; 2021 Jan; 41(1):37-50. PubMed ID: 33283635
[TBL] [Abstract][Full Text] [Related]
3. Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study.
Gallacher D; Kimani P; Stallard N
Med Decis Making; 2021 May; 41(4):476-484. PubMed ID: 33626961
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma.
Bakker LJ; Thielen FW; Redekop WK; Groot CU; Blommestein HM
BMC Med Res Methodol; 2023 May; 23(1):132. PubMed ID: 37248477
[TBL] [Abstract][Full Text] [Related]
6. Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer.
Gray J; Sullivan T; Latimer NR; Salter A; Sorich MJ; Ward RL; Karnon J
Med Decis Making; 2021 Feb; 41(2):179-193. PubMed ID: 33349137
[TBL] [Abstract][Full Text] [Related]
7. Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry.
Chen EY; Leontyeva Y; Lin CN; Wang JD; Clements MS; Dickman PW
Med Decis Making; 2024 Apr; 44(3):269-282. PubMed ID: 38314657
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection.
Bullement A; Willis A; Amin A; Schlichting M; Hatswell AJ; Bharmal M
BMC Med Res Methodol; 2020 May; 20(1):103. PubMed ID: 32375680
[TBL] [Abstract][Full Text] [Related]
9. Comparison of survival analysis approaches to modelling age at first sex among youth in Kisesa Tanzania.
Materu J; Konje ET; Urassa M; Marston M; Boerma T; Todd J
PLoS One; 2023; 18(9):e0289942. PubMed ID: 37676876
[TBL] [Abstract][Full Text] [Related]
10. Projecting overall survival in health-economic models: uncertainty and maturity of data.
Roze S; Bertrand N; Eberst L; Borget I
Curr Med Res Opin; 2023 Mar; 39(3):367-374. PubMed ID: 36628431
[TBL] [Abstract][Full Text] [Related]
11. Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment.
Che Z; Green N; Baio G
Med Decis Making; 2023 Apr; 43(3):299-310. PubMed ID: 36314662
[TBL] [Abstract][Full Text] [Related]
12. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
[TBL] [Abstract][Full Text] [Related]
13. Comparing current and emerging practice models for the extrapolation of survival data: a simulation study and case-study.
Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
BMC Med Res Methodol; 2021 Nov; 21(1):263. PubMed ID: 34837957
[TBL] [Abstract][Full Text] [Related]
14. Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations.
Gallacher D; Kimani P; Stallard N
Pharmacoeconomics; 2022 Jan; 40(1):109-120. PubMed ID: 34580839
[TBL] [Abstract][Full Text] [Related]
15. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
16. A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.
Grant TS; Burns D; Kiff C; Lee D
Pharmacoeconomics; 2020 Apr; 38(4):385-395. PubMed ID: 31848900
[TBL] [Abstract][Full Text] [Related]
17. Parametric Survival Extrapolation of Early Survival Data in Economic Analyses: A Comparison of Projected Versus Observed Updated Survival.
Everest L; Blommaert S; Chu RW; Chan KKW; Parmar A
Value Health; 2022 Apr; 25(4):622-629. PubMed ID: 35365306
[TBL] [Abstract][Full Text] [Related]
18. How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness.
Kearns B; Stevens J; Ren S; Brennan A
Pharmacoeconomics; 2020 Feb; 38(2):193-204. PubMed ID: 31761997
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
